FRANCIS TORRES: Open Payments
NPI 1659979052 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,393 in 64 payments from 14 companies in 2025. Trend: 2023 $640 · 2024 $1,134 · 2025 $3,393
Food & beverage: $1,925Consulting: $1,105Education: $334Travel & lodging: $29
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $1,283 |
| Verona Pharma, Inc. | 7 | $717 |
| AstraZeneca Pharmaceuticals LP | 12 | $534 |
| JAZZ PHARMACEUTICALS INC. | 5 | $226 |
| Actelion Pharmaceuticals US, Inc. | 4 | $176 |
| Electromed, Inc. | 2 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
| INOGEN, INC. | 6 | $57 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Baxter Healthcare | 1 | $48 |
Products named: Ohtuvayre, DUPIXENT, AIRSUPRA, XYWAV, SMARTVEST, FASENRA, OPSUMIT, GLASSIA.
Industry payments across NV — which companies pay providers there.
